SEC
|
Sitko Bradley
|
Chief Investment Officer
|
|
+2K
|
$25.39
|
+$50.78K
|
|
SEC
|
BURNS THOMAS M.
|
SVP, Finance & CFO
|
|
-10K
|
$25.38
|
-$266.03K
|
|
SEC
|
Hughes Owen
|
Chief Executive Officer
|
|
-26K
|
$25.38
|
-$650.67K
|
|
SEC
|
LIMBER JOSEPH M
|
N/A
|
|
+30K
|
$25.34
|
+$760.20K
|
|
SEC
|
Sitko Bradley
|
Chief Investment Officer
|
|
+2K
|
$24.70
|
+$49.40K
|
|
SEC
|
BURNS THOMAS M.
|
SVP, Finance & CFO
|
|
+1K
|
$25.46
|
+$25.46K
|
|
SEC
|
Sitko Bradley
|
Chief Investment Officer
|
|
+1.2K
|
$21.04
|
+$26.19K
|
|
SEC
|
Sitko Bradley
|
Chief Investment Officer
|
|
+4.1K
|
$23.89
|
+$98.76K
|
|
SEC
|
Sitko Bradley
|
Chief Investment Officer
|
|
+545
|
$25.64
|
+$13.97K
|
|
SEC
|
Sitko Bradley
|
Chief Investment Officer
|
|
+300
|
$25.90
|
+$7.77K
|
|
SEC
|
BURNS THOMAS M.
|
SVP, Finance & CFO
|
|
-9.8K
|
$29.94
|
-$292.66K
|
|
SEC
|
Hughes Owen
|
Chief Executive Officer
|
|
-22K
|
$29.95
|
-$655.34K
|
|
SEC
|
Sitko Bradley
|
Chief Investment Officer
|
|
+1.8K
|
$14.20
|
+$24.85K
|
|
SEC
|
Hughes Owen
|
Exec Chairman and Interim CEO
|
|
+1K
|
$13.83
|
+$13.83K
|
|
SEC
|
Hughes Owen
|
Exec Chairman and Interim CEO
|
|
+2.5K
|
$14.43
|
+$36.08K
|
|
SEC
|
Sitko Bradley
|
Chief Investment Officer
|
|
+1.5K
|
$17.13
|
+$25.70K
|
|
SEC
|
Hughes Owen
|
Interim CEO
|
|
+2K
|
$23.63
|
+$47.26K
|
|
SEC
|
Sitko Bradley
|
Chief Investment Officer
|
|
+850
|
$19.00
|
+$16.15K
|
|
SEC
|
Sitko Bradley
|
Chief Investment Officer
|
|
+1K
|
$19.50
|
+$19.50K
|
|
SEC
|
Sitko Bradley
|
Chief Investment Officer
|
|
+500
|
$23.20
|
+$11.60K
|
|
SEC
|
Sitko Bradley
|
Chief Investment Officer
|
|
+3.5K
|
$20.88
|
+$73.08K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+22K
|
$18.91
|
+$420.73K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+25K
|
$16.61
|
+$409.30K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+56K
|
$17.59
|
+$990.48K
|
|
SEC
|
BURNS THOMAS M.
|
SVP, Finance & CFO
|
|
-2K
|
$31.66
|
-$63.32K
|
|
SEC
|
Neal James R
|
CEO
|
|
-25K
|
$29.84
|
-$746.00K
|
|
SEC
|
Neal James R
|
CEO
|
|
-9K
|
$33.62
|
-$303.50K
|
|
SEC
|
BURNS THOMAS M.
|
SVP, Finance & CFO
|
|
+1K
|
$25.00
|
+$25.00K
|
|
SEC
|
Neal James R
|
CEO
|
|
+8K
|
$25.00
|
+$200.00K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
-652K
|
$38.36
|
-$25.00M
|
|
SEC
|
VAN NESS W DENMAN
|
N/A
|
|
+5.7K
|
$10.41
|
+$59.33K
|
|
SEC
|
BURNS THOMAS M.
|
SVP, Finance & CFO
|
|
+2K
|
$22.86
|
+$45.72K
|
|
SEC
|
Hernday Natasha
|
N/A
|
|
+4K
|
$25.00
|
+$100.00K
|
|
SEC
|
Neal James R
|
CEO
|
|
+8K
|
$23.63
|
+$189.04K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+200K
|
$25.00
|
+$5.00M
|
|
SEC
|
PERRY MATTHEW D
|
N/A
|
|
+200K
|
$25.00
|
+$5.00M
|
|
SEC
|
BURNS THOMAS M.
|
SVP, Finance & CFO
|
|
-12K
|
$32.69
|
-$392.28K
|
|
SEC
|
Neal James R
|
CEO
|
|
-20K
|
$32.81
|
-$656.20K
|
|
SEC
|
BURNS THOMAS M.
|
SVP, Finance & CFO
|
|
-8K
|
$26.11
|
-$208.88K
|
|
SEC
|
Neal James R
|
CEO
|
|
-10K
|
$26.02
|
-$260.20K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+51K
|
$18.34
|
+$942.09K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+7.7K
|
$18.77
|
+$145.22K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+36K
|
$18.71
|
+$666.47K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+28K
|
$19.40
|
+$546.60K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+6.2K
|
$19.47
|
+$119.99K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+27K
|
$18.46
|
+$498.83K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+1.3M
|
$13.00
|
+$16.29M
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+8.3K
|
$17.20
|
+$142.14K
|
|
SEC
|
Neal James R
|
CEO
|
|
+1K
|
$14.50
|
+$14.50K
|
|
SEC
|
Neal James R
|
CEO
|
|
+1K
|
$16.41
|
+$16.41K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+4.4K
|
$14.52
|
+$64.45K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+118K
|
$17.94
|
+$2.12M
|
|
SEC
|
Neal James R
|
CEO
|
|
+1.2K
|
$22.00
|
+$25.96K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+845K
|
$22.00
|
+$18.60M
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+28K
|
$14.63
|
+$408.37K
|
|
SEC
|
VAN NESS W DENMAN
|
N/A
|
|
-130
|
$14.71
|
-$1.91K
|
|
SEC
|
Neal James R
|
CEO
|
|
+678
|
$13.00
|
+$8.81K
|
|
SEC
|
VAN NESS W DENMAN
|
N/A
|
|
+800
|
$13.00
|
+$10.40K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+25K
|
$14.19
|
+$354.75K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+36K
|
$14.46
|
+$527.25K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+61K
|
$14.71
|
+$897.65K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+9.8K
|
$14.91
|
+$146.12K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+30K
|
$15.10
|
+$448.47K
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+72K
|
$14.17
|
+$1.02M
|
|
SEC
|
LAMPERT MARK N
|
N/A
|
|
+32K
|
$13.48
|
+$431.23K
|
|
SEC
|
VAN NESS W DENMAN
|
N/A
|
|
+2.2K
|
$9.28
|
+$20.09K
|
|
SEC
|
Neal James R
|
CEO
|
|
+4K
|
$13.26
|
+$53.04K
|
|
SEC
|
Varian John
|
N/A
|
|
-40K
|
$6.24
|
-$246.73K
|
|
SEC
|
BURNS THOMAS M.
|
VP, Finance & Chief Financial
|
|
-2.6K
|
$5.40
|
-$14.03K
|
|
SEC
|
Neal James R
|
VP Business Development
|
|
-5.1K
|
$5.40
|
-$27.57K
|
|
SEC
|
Neal James R
|
VP Business Development
|
|
-195
|
$4.52
|
-$881.40
|
|
SEC
|
Neal James R
|
VP Business Development
|
|
-125
|
$5.15
|
-$643.75
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-3.2K
|
$5.75
|
-$18.57K
|
|
SEC
|
Varian John
|
N/A
|
|
-14K
|
$5.75
|
-$77.91K
|
|
SEC
|
Neal James R
|
VP Business Development
|
|
-150
|
$5.25
|
-$787.50
|
|
SEC
|
Neal James R
|
VP Business Development
|
|
-2.5K
|
$0.45
|
-$1.13K
|
|
SEC
|
BURNS THOMAS M.
|
VP, Finance & Chief Financial
|
|
-19K
|
$0.78
|
-$15.01K
|
|
SEC
|
Neal James R
|
VP Business Development
|
|
-20K
|
$0.78
|
-$15.45K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-24K
|
$0.78
|
-$18.87K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-15K
|
$0.78
|
-$11.53K
|
|
SEC
|
Varian John
|
CEO
|
|
-81K
|
$0.78
|
-$63.20K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-8K
|
$1.01
|
-$8.08K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-8K
|
$1.37
|
-$10.96K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-8K
|
$1.35
|
-$10.80K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-8K
|
$1.04
|
-$8.32K
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
-11M
|
$1.09
|
-$11.99M
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-5K
|
$4.60
|
-$23.00K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$4.49
|
-$44.90K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-33K
|
$4.55
|
-$151.97K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$3.64
|
-$36.40K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-1.8K
|
$3.60
|
-$6.44K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$3.34
|
-$33.40K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$3.86
|
-$38.60K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-33K
|
$3.94
|
-$129.00K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$3.72
|
-$37.20K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$3.52
|
-$35.20K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-5K
|
$3.52
|
-$17.60K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$3.46
|
-$34.60K
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
-2.2M
|
$3.81
|
-$8.44M
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-5K
|
$3.55
|
-$17.75K
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
-744K
|
$3.67
|
-$2.73M
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
-1.6M
|
$4.26
|
-$6.84M
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
-1M
|
$4.46
|
-$4.61M
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-1.6K
|
$4.63
|
-$7.41K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$4.49
|
-$44.90K
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
-392K
|
$4.62
|
-$1.81M
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
-2.4M
|
$4.79
|
-$11.36M
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-5K
|
$5.51
|
-$27.55K
|
|
SEC
|
Neal James R
|
N/A
|
|
-1.7K
|
$5.67
|
-$9.51K
|
|
SEC
|
Neal James R
|
VP Business Development
|
|
-1K
|
$5.03
|
-$5.19K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-5K
|
$4.55
|
-$22.75K
|
|
SEC
|
KURLAND FRED
|
CFO & VP Finance
|
|
-8.8K
|
$3.89
|
-$34.13K
|
|
SEC
|
Neal James R
|
VP Business Development
|
|
-4.4K
|
$3.89
|
-$17.07K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-8.2K
|
$3.89
|
-$32.07K
|
|
SEC
|
Varian John
|
CEO
|
|
-59K
|
$3.89
|
-$228.90K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-5K
|
$4.33
|
-$21.65K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-5K
|
$4.57
|
-$22.85K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$3.87
|
-$38.70K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-5K
|
$4.09
|
-$20.45K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-5K
|
$4.59
|
-$22.95K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$4.56
|
-$45.60K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-10K
|
$4.56
|
-$45.60K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-5K
|
$4.31
|
-$21.55K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-27K
|
$4.34
|
-$116.09K
|
|
SEC
|
KURLAND FRED
|
CFO & VP Finance
|
|
-10K
|
$4.31
|
-$44.83K
|
|
SEC
|
Neal James R
|
VP Business Development
|
|
-6.6K
|
$4.61
|
-$30.35K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-5.9K
|
$4.31
|
-$25.30K
|
|
SEC
|
Varian John
|
CEO
|
|
-65K
|
$4.30
|
-$278.74K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-5K
|
$3.83
|
-$19.15K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$4.03
|
-$40.30K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-5K
|
$4.68
|
-$23.40K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-12K
|
$4.54
|
-$52.57K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$4.54
|
-$45.40K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-1.8K
|
$4.22
|
-$7.53K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$3.55
|
-$35.50K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-10K
|
$3.84
|
-$38.40K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$4.06
|
-$40.60K
|
|
SEC
|
Klein Thomas
|
Chief Commercial Officer
|
|
-31K
|
$6.32
|
-$195.70K
|
|
SEC
|
KURLAND FRED
|
CFO & VP Finance
|
|
-5.9K
|
$6.32
|
-$37.38K
|
|
SEC
|
Neal James R
|
VP Business Development
|
|
-2.7K
|
$6.32
|
-$16.88K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-18K
|
$6.31
|
-$111.37K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-3.4K
|
$6.32
|
-$21.61K
|
|
SEC
|
Varian John
|
CEO
|
|
-21K
|
$6.32
|
-$134.80K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$6.03
|
-$60.30K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-6K
|
$7.55
|
-$45.30K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$7.55
|
-$75.50K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-6K
|
$8.27
|
-$49.62K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$8.28
|
-$82.80K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-20K
|
$8.00
|
-$160.00K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-6K
|
$5.67
|
-$34.02K
|
|
SEC
|
Varian John
|
CEO
|
|
-10K
|
$5.44
|
-$54.40K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-20K
|
$6.00
|
-$120.00K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-4.7K
|
$4.54
|
-$21.32K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-1.3K
|
$4.08
|
-$5.32K
|
|
SEC
|
Varian John
|
CEO
|
|
-65K
|
$3.95
|
-$256.48K
|
|
SEC
|
KURLAND FRED
|
CFO & VP Finance
|
|
-12K
|
$3.91
|
-$48.21K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-8.3K
|
$3.91
|
-$32.63K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-746
|
$4.71
|
-$3.51K
|
|
SEC
|
Varian John
|
Director and CEO
|
|
-10K
|
$4.60
|
-$46.00K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-6K
|
$4.53
|
-$27.18K
|
|
SEC
|
Varian John
|
Director and CEO
|
|
-10K
|
$4.59
|
-$45.90K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-6K
|
$3.74
|
-$22.44K
|
|
SEC
|
Varian John
|
Director and CEO
|
|
-62K
|
$3.87
|
-$238.57K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-11K
|
$3.86
|
-$40.61K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Exec. VP & CSO
|
|
-6K
|
$3.86
|
-$23.17K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-6K
|
$4.71
|
-$28.26K
|
|
SEC
|
Varian John
|
Director and CEO
|
|
-10K
|
$4.81
|
-$48.10K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-1.8K
|
$4.16
|
-$7.48K
|
|
SEC
|
RUBIN PAUL D
|
Sr. VP Clinical Dev. & CMO
|
|
-7K
|
$3.29
|
-$23.00K
|
|
SEC
|
KURLAND FRED
|
CFO & VP Finance
|
|
-9.1K
|
$2.56
|
-$23.32K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
Executive Vice President
|
|
-8.8K
|
$2.56
|
-$22.46K
|
|
SEC
|
Varian John
|
Director and CEO
|
|
-41K
|
$2.56
|
-$103.90K
|
|
SEC
|
BAKER FELIX
|
N/A
|
|
+4.7M
|
$3.00
|
+$14.17M
|
|
SEC
|
VAN NESS W DENMAN
|
N/A
|
|
-698
|
$1.60
|
-$1.12K
|
|
SEC
|
KURLAND FRED
|
CFO & VP Finance
|
|
+5K
|
$3.26
|
+$16.30K
|
|
SEC
|
VAN NESS W DENMAN
|
N/A
|
|
-680
|
$0.92
|
-$625.60
|
|
SEC
|
DELLIO CLARENCE L
|
Sr VP, Operations and COO
|
|
-11K
|
$1.41
|
-$15.47K
|
|
SEC
|
MARGOLIN CHRISTOPHER J
|
VP, General Counsel & Sec'y
|
|
-54K
|
$1.03
|
-$55.31K
|
|
SEC
|
DELLIO CLARENCE L
|
Sr VP, Operations and COO
|
|
-4.3K
|
$2.51
|
-$10.78K
|
|
SEC
|
DELLIO CLARENCE L
|
Sr VP, Operations and COO
|
|
-4K
|
$4.75
|
-$19.00K
|
|
SEC
|
MENDELL STEVEN C
|
N/A
|
|
-1K
|
$4.88
|
-$4.88K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
CSMO
|
|
-75K
|
$4.97
|
-$372.75K
|
|
SEC
|
DAVIS PETER B
|
VP, Finance & CFO
|
|
+5K
|
$4.79
|
+$23.95K
|
|
SEC
|
DELLIO CLARENCE L
|
Sr VP, Operations and COO
|
|
-16K
|
$7.49
|
-$119.61K
|
|
SEC
|
MARGOLIN CHRISTOPHER J
|
VP, General Counsel & Sec'y
|
|
-40K
|
$7.56
|
-$302.40K
|
|
SEC
|
SCANNON PATRICK J MD PHD
|
CSMO
|
|
-105K
|
$6.54
|
-$686.70K
|
|